$HIPH (OTC: HIPH) Announces Joint Venture with CBD Pet

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
321
$ HIPH (OTC: HIPH) Announces Joint Venture with CBD Pet Product Manufacturer LinkRes Pets (OTC: LRSV) to Produce CBD Pet Water
GlobeNewswire•May 1, 2019

The Company enters $75 billion pet industry with the JV agreement

PLAYA VISTA, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- American Premium Water Corporation (HIPH) (“the Company”) announces that it has entered into a letter of intent (LOI) with Link Reservation, Inc. (LRSV) to form a joint-venture (JV) to produce a CBD-infused water specifically designed for consumption by household pets. This product will be the first pet CBD beverage on the market. It will be sold under the LinkRes Pet brand “powered by” LALPINA CBD. The product is expected to be released in 2019.

CEO American Premium Water Corporation, Ryan Fishoff commented, “I am excited to announce this joint venture with LinkRes Pets to produce the first CBD-beverage for pets! The consumer market is huge, and there are many studies that have shown how pet health can benefit from consumption of CBD. This is a great partnership for the Company. We will be providing our proprietary Hydro-Nano formulation to be used in the manufacture of the product by LinkRes. They will handle logistics and distribution; while the Company will assist with marketing. This partnership will provide great exposure for the LALPINA CBD brand. Every pet owner is also a potential customer for our LALPINA CBD water. Pet owners statistically are more affluent than non-pet owners; co-branding with LinkRes will bring additional exposure to our Company to a very captive consumer base.”

Rene Lauritsen, President and CEO of LinkRes Pets commented, “It is great to partner with a company like American Premium Water Corp. Their Hydro Nano technology is very advanced in the marketplace that is backed with scientific data, which aligns with the LinkRes brand. Co-branding with the LALPINA CBD is the key element that will be essential for a successful launch creating this brand new product category (Pet CBD Beverages). This partnership will be very impactful for LinkRes Pets, and I look forward tow working with Ryan and his team in the coming months developing this product.”

LinkRes Pets (www.linkrespet.com) produces CBD products specifically tailored for cats, dogs and horses. LinkRes current product offering is exclusively CBD oil. The partnership with American Premium Water would be their first product outside of CBD oil. The American Pet Products Association estimates that the US pet product industry will be worth over $75 billion in 2019. New Frontier Data projects that the CBD Pet Product Market will reach $125 million in sales by 2022. And according to a report by Research and Marketing, over 55% of US households own a pet, and are more likely to be in a higher income household than non-pet owners.

“There is a huge opportunity with this partnership. Currently there are no pet CBD beverages on the market, and the pet beverage market itself is very limited and underdeveloped. We are going to be starting out with a huge head start. This product has the potential to add $1-3 million dollars of incremental revenue to the P&L once full distribution is reached. This partnership is an example of how the Company’s IP and technology acquisition strategy is paying dividends. The Company is leveraging its proprietary Hydro-Nano formulation to generate incremental revenue. The Company will continue to seek partnership opportunities in new categories, similar to our partnership with Hanlon’s Brewery in the UK. We are currently engaged in discussions with other potential partners about leveraging the Company’s technology into new product categories and applications. I look forward to providing shareholders with updates on these conversations when developments are ready to share.” concluded Mr. Fishoff

For more information contact info@americanpremiumwater.com

About American Premium Water Corp.

American Premium Water (HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of hydrogen and Nano technologies paired with cannabidiol (CBD) to treat health disorders and enhance quality of life. This business model aims to market emerging fashion brands by leveraging classic retail partners and incorporating disruptive blockchain technologies to expand the retail footprint. The company’s portfolio includes the LALPINA Hydro and LALPINA Hydro CBD brands (www.LalpinaInc.com), LALPINA Productions, LALPINA Records, Canyon Create (www.canyoncreate.com), Vanexxe (www.vanexxe.com) Gents (www.gentsco.com), Worthy, and blockchain platform FashionCoinX (www.FashionCoinX.com).

Safe Harbor Notice

Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC" EDGAR database.

This press release is issued on behalf of the Board of Directors of American Premium Water Corporation.

Contact Information:
Media Contact
Email: info@americanpremiumwater.com
+1(888) 983-0054
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 21

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 7

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 24

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 25

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 15

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 22

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 33

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 16

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 7

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading

Top 5 Most Recently Viewed Articles

Pieridae Energy Limited Reports Strong Q3 2024 Performance

Updated Category News Views 58

Strong Financial and Operational Results from Pieridae Energy CALGARY, Alberta - Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) has announced its third quarter 2024 financial and operating results, showcasing an impressive production output and robust financial performance. The company achieved a production rate of 23,116 barrels of oil...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 136

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
Study Confirms Safety of Combined Eye Drops for Surgery Use

Updated Category News Views 172

Introduction to the Study A five-year pharmacovigilance study has confirmed the excellent safety profile of a fixed-dose combination eye drop developed by NTC. This eye drop combines an anti-inflammatory steroid and a quinolone antibiotic, designed for preventing and treating inflammation, as well as preventing infection after cataract surgery. Study Overview The findings...

Continue Reading
New Concerns Arise for Roblox Amid Allegations of Misreported Metrics

Updated Category News Views 203

Allegations Against Roblox: A Closer Look Roblox Corp (NYSE: RBLX) has recently come under fire after a report from Hindenburg Research highlighted potential discrepancies in its reported user metrics, leading to a notable decline in its stock prices. The gaming platform is being questioned for allegedly overstating its user metrics, including daily active users (DAUs)...

Continue Reading
uniQure N.V. Faces Investigation Amid Securities Fraud Concerns

Updated Category News Views 155

Understanding the uniQure N.V. Investigation Currently, uniQure N.V. is under investigation concerning possible violations of securities laws. This inquiry has raised significant concerns for shareholders and potential investors, driving many to seek assistance in understanding their rights moving forward. The investigation is being led by the DJS Law Group, an...

Continue Reading